首页> 外文期刊>Journal of Evolutionary Biochemistry and Physiology: A Journal of Original Papers and Reviews on Evolutionary, Comparative, and Ecological Aspects of Physiology, Biochemistry, and Morphology >Advances in the Study of Structure and Function of G Protein-Coupled Receptors (About Awarding the Nobel Prize for Chemistry in 2012 to Robert Leikowitz and Brian Kobilka)
【24h】

Advances in the Study of Structure and Function of G Protein-Coupled Receptors (About Awarding the Nobel Prize for Chemistry in 2012 to Robert Leikowitz and Brian Kobilka)

机译:G蛋白偶联受体的结构和功能研究进展(关于2012年授予罗伯特·莱科维茨和布莱恩·科比尔卡的诺贝尔化学奖)

获取原文
获取原文并翻译 | 示例
           

摘要

The 2012 Nobel Prize for Chemistry was awarded to Robert Lefkowitz and Brian Kobilka "for study in G-protein-coupled receptors" (GPCR). In this review there are discussed and analyzed the most important discoveries of these Nobel Laureates dealing with study of structure and functions of GPCR. In the 1980s they were the first in the world to clone GPCR—the β2-adrenergic receptor. After 20 years the group headed by B. Kobilka first obtained this receptor in the crystallic form and established its three-dimensional structure. In the course of the studies, unique approaches were developed for purifications and crystallization of other receptors. In the 1980s, R. Lefkowitz and his colleagues discovered proteins β-arrestins that regulate the signal transduction realized via GPCR. Subsequently they showed β-arrestins to be the most important participants of signal transduction and to be responsible for transduction of signal from the receptor activated with hormone to intracellular signal cascades regardless of heterotrimeric G-proteins. These and other outstanding discoveries of R. Lefkowitz and B. Kobilka have become the ground of the new field of molecular biology and pharmacology—molecular endocrinology of GPCR.
机译:Robert Lefkowitz和Brian Kobilka凭借“研究G蛋白偶联受体”(GPCR)获得了2012年诺贝尔化学奖。在这篇综述中,讨论和分析了这些诺贝尔奖获得者与GPCR的结构和功能有关的最重要发现。在1980年代,它们是世界上第一个克隆GPCR(β2-肾上腺素受体)的克隆。 20年后,由B. Kobilka领导的小组首先获得了这种晶体形式的受体,并建立了其三维结构。在研究过程中,开发了独特的方法来纯化和结晶其他受体。在1980年代,R。Lefkowitz及其同事发现了β-arrestin蛋白,它们调节通过GPCR实现的信号转导。随后,他们表明β-arrestin是信号转导的最重要参与者,并且负责将信号从激素激活的受体转导到细胞内信号级联反应,而与异源三聚体G蛋白无关。 R. Lefkowitz和B. Kobilka的这些以及其他杰出发现已经成为分子生物学和药理学新领域的基础-GPCR的分子内分泌学。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号